← All trials
NCT05531591
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2019
- Primary completion
- Jan 31, 2024
- Completion date
- Feb 28, 2025
- First posted
- Sep 8, 2022
- Last posted
- Sep 8, 2022
- Enrollment
- 600
- Arms / groups
- 5 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of TorontoLead sponsor
- National Institute of Mental Health (NIMH)Collaborator
- University of TorontoOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.